Emergent BioSolutions Q3 2023 Earnings Presentation

Emergent BioSolutions presents Q3 2023 earnings results covering operational performance, COVID-19 product demand trends, and manufacturing facility challenges. The presentation addresses competitive market pressures, regulatory compliance efforts, and financial metrics including EBITDA from operations adjusted for non-controlling interests.